The shares of Advanced Disposal Services, Inc. (NYSE:ADSW) has been pegged with a rating of Hold by Stifel in its latest research note that was published on April 11th, 2019. The research company has also assigned a $30 price target. Stifel wasnâ€™t the only research firm that published a report of Advanced Disposal Services, Inc., with other equities research analysts also giving their opinion on the stock. BofA/Merrill advised investors in its research note published on February 19th, 2019, to Underperform the ADSW stock while also putting a $27 price target. The stock had earned Sector Weight rating from KeyBanc Capital Mkts when it published its report on February 5th, 2019. The stock was given Neutral rating by BofA/Merrill in its report released on October 24th, 2018. Morgan Stanley was of a view that ADSW is Equal-Weight in its latest report on October 12th, 2018 while giving it a price target of $27. Stifel thinks that ADSW is worth Buy rating. This was contained in the firmâ€™s report on December 11th, 2017 in which the stockâ€™s price target was also moved to $28.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 2 believe it has the potential for further growth, thus rating it as Hold while 4 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $28.78. The price of the stock the last time has raised by 48.72% from its Week high price while it is raised higher than its 52-Week low price. A look at the stockâ€™s other technical shows that its 14-day RSI now stands at 79.26.
The shares of the company added by 1.34% during the trading session on Tuesday, reaching a low of $32.16 while ending the day at $32.42. During the trading session, a total of 9.64 million shares were traded which represents a -1557417.85% decline from the average session volume which is 619.22K shares. ADSW had ended its last session trading at 31.99. Advanced Disposal Services, Inc. currently has a market cap of $2.87B, while its P/E ratio stands at 308.76, while its P/E earnings growth sits at 1.84. Advanced Disposal Services, Inc. debt-to-equity ratio currently stands at 2.09, while its quick ratio hovers at 0.70. ADSW 52-week low price stands at $21.80 while its 52-week high price is $32.99.
The company in its last quarterly report recorded $0.13 earnings per share which is below the $0.13 predicted by most analysts. The Advanced Disposal Services, Inc. generated $394.80 million in revenue during the last quarter, which is slightly higher than the $386.69 million predicted by analysts. In the second quarter last year, the firm recorded $0.17 earnings per share. Compared to the same quarter last year, the firmâ€™s revenue was down by -30.77%. Advanced Disposal Services, Inc. has the potential to record 0.11 EPS for the current fiscal year, according to equities analysts.
Investment analysts at BofA/Merrill published a research note on February 7th, 2019 where it informed investors and clients that Abbott Laboratories (NYSE:ABT) is now rated as Buy. Their price target on the stock stands at $81. BofA/Merrill also rated ABT as Downgrade on February 19th, 2019, with its price target of suggesting that ABT could surge by 5.42% from its current share price. Even though the stock has been trading at $77.50/share, analysts expect it to surge higher by -1.45% to reach $80.76/share. It started the day trading at $78.70 and traded between $76.06 and $76.38 throughout the trading session.
A look at its technical shows that ABTâ€™s 50-day SMA is 77.41 while its 200-day SMA stands at 70.53. The stock has a high of $80.74 for the year while the low is $56.81. The companyâ€™s P/E ratio currently sits at 54.87, while the P/B ratio is 4.41. At the moment, only of Abbott Laboratories shares were sold short. The companyâ€™s average trading volume currently stands at 5.80M shares, which means that the short-interest ratio is just 2.76 days. Over the past seven days, the company moved, with its shift of -2.91%. Looking further, the stock has raised 8.39% over the past 90 days while it gained 10.17% over the last six months.
The change in the stockâ€™s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more ABT shares, increasing its portfolio by +3.96% during the last quarter. This move now sees The Vanguard Group Inc purchasing 5,407,080 shares in the last quarter, thus it now holds 141,857,059 shares of ABT, with a total valuation of $11,340,053,296. Capital Research Management Co meanwhile sold more ABT shares in the recently filed quarter, changing its stake to $9,746,951,979 worth of shares. BlackRock Fund Advisors followed the path by increasing its ABT portfolio by +2.94% in the quarter. This means that BlackRock Fund Advisors bought 2,312,683 shares in the last quarter and now controls 80,845,552 shares of the ABT stock, with the valuation hitting $6,462,793,427.
Similarly, Wellington Management Co LLP decreased its Abbott Laboratories shares by -0.19% during the recently filed quarter. After selling -78,800 shares in the last quarter, the firm now controls 41,305,569 shares of Abbott Laboratories which are valued at $3,301,967,186. In the same vein, Massachusetts Financial Services decreased its Abbott Laboratories shares by during the most recent reported quarter. The firm sold -4,956,088 shares during the quarter which decreased its stakes to 33,640,461 shares and is now valued at $2,689,218,452. Following these latest developments, around 0.30% of Abbott Laboratories stocks are owned by institutional investors and hedge funds.